IPO Update: With Just Two Small Offerings In Q2, What’s Next?

Seven US Launches In First Half Vs. 12 In H1 2024

 
• By Mandy Jackson
  
Biopharma firms are feeling blue with the IPO window essentially closed for now (Shutterstock)

More from Financing

More from Business